The clinical criteria were classified as: Cured=complete remission of signs and symptoms. lmproved=symptoms still present, but showing indications of improvement. Failure= no improvement. Unassessable= improvement but another antibiotic given concurrently.
Results Table I shows the pathological cases treated with cefuroxime. There were 16 respiratory tract infections (3 upper and 13 lower) , 2 urinary tract infections, I septicxmia and 1 case of otitis. Tables 2 and 3 show the results of treatment expressed according to bacteriological and clinical criteria in 9 infants aged between 6 months and 1 year, to whom cefuroxime was administered at the mean daily dose of 52.23 ±4.15 mg/kg for a mean duration of 10.9±2.3 days. Bacteriological success was recorded in 8 cases, I case being unassessable. Clinical cure was reached in 1 case, reported to have cried for longer than usual after the injection. Blood samples for determination of the serum levels of cefuroxime were taken at different times after the administration. The results support a quick absorption of the antibiotic from the inoculation site, the peaks of about 25 ,ug/ml 25-35 min after administration falling to about I jtg/ ml at 6 h, or in the younger age group (infants) 8 h after the injection. 
Conclusions
With the 20 children in this study, cefuroxime achieved bacteriological success in 14 cases (70%), failure in one case (5 %) and its effects twere unassessable in 5 cases (25 %). Clinical efficacy was reported as excellent or good in 17 cases (85 %) and 3 cases were unassessable. Local and clinical tolerance was good, with no side effects as evidenced by laboratory parameters. The absorption of cefuroxime from the injection site was rapid, with high peak levels and good overall serum concentrations.
